Sinew Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 57

Employees

  • Stock Symbol
  • 6634

Stock Symbol

  • Share Price
  • $1.79
  • (As of Monday Closing)

Sinew Pharma General Information

Description

Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Room C516, Building C
  • No. 99, Lane 130, Section 1 Yanjiuyuan Road, Nangang District
  • Taipei, 115-71
  • Taiwan
+886 02
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
ROCO
Vertical(s)
Corporate Office
  • Room C516, Building C
  • No. 99, Lane 130, Section 1 Yanjiuyuan Road, Nangang District
  • Taipei, 115-71
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinew Pharma Stock Performance

As of 16-Nov-2026, Sinew Pharma’s stock price is $1.79. Its current market cap is $128M with 71.3M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.79 $1.83 $0.91 - $2.69 $128M 71.3M 98.8K -$0.05

Sinew Pharma Financials Summary

As of 30-Jun-2026, Sinew Pharma has a trailing 12-month revenue of $1.51K.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 129,978 54,544 66,132 111,636
Revenue 2 2 0
EBITDA (3,909) (3,845) (4,248) (5,047)
Net Income (3,812) (3,967) (4,686) (5,487)
Total Assets 33,463 36,056 37,287 44,369
Total Debt 385 486 86 302
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sinew Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sinew Pharma‘s full profile, request access.

Request a free trial

Sinew Pharma Patents

Sinew Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021513548-A Methods and compositions for preventing, reducing or eradicating the toxicity caused by acetaminophen (apap) Pending 14-Feb-2018
AU-2019220062-A1 Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) Active 14-Feb-2018
AU-2019220062-B2 Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) Active 14-Feb-2018
CA-3090029-A1 Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) Pending 14-Feb-2018
EP-3752140-A1 Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) Pending 14-Feb-2018 A61K31/78
To view Sinew Pharma’s complete patent history, request access »

Sinew Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sinew Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Sinew Pharma’s complete esg history, request access »

Sinew Pharma FAQs

  • When was Sinew Pharma founded?

    Sinew Pharma was founded in 2014.

  • Where is Sinew Pharma headquartered?

    Sinew Pharma is headquartered in Taipei, Taiwan.

  • What is the size of Sinew Pharma?

    Sinew Pharma has 57 total employees.

  • What industry is Sinew Pharma in?

    Sinew Pharma’s primary industry is Pharmaceuticals.

  • Is Sinew Pharma a private or public company?

    Sinew Pharma is a Public company.

  • What is Sinew Pharma’s stock symbol?

    The ticker symbol for Sinew Pharma is 6634.

  • What is the current stock price of Sinew Pharma?

    As of 16-Nov-2026 the stock price of Sinew Pharma is $1.79.

  • What is the current market cap of Sinew Pharma?

    The current market capitalization of Sinew Pharma is $128M.

  • What is Sinew Pharma’s current revenue?

    The trailing twelve month revenue for Sinew Pharma is $1.51K.

  • What is Sinew Pharma’s annual earnings per share (EPS)?

    Sinew Pharma’s EPS for 12 months was -$0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process